The global Neurological Biomarkers market size was valued at US$ 8938 million in 2024 and is forecast to a readjusted size of USD 19260 million by 2031 with a CAGR of 11.7% during review period.
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
This report is a detailed and comprehensive analysis for global Neurological Biomarkers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurological Biomarkers market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Neurological Biomarkers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Neurological Biomarkers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Neurological Biomarkers market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurological Biomarkers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurological Biomarkers market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, Roche, Illumina, Bio-Rad Laboratories, QIAGEN, Myriad RBM, Cisbio Bioassays, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Neurological Biomarkers market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
麻豆原创 segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
Major players covered
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurological Biomarkers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Biomarkers, with price, sales quantity, revenue, and global market share of Neurological Biomarkers from 2020 to 2025.
Chapter 3, the Neurological Biomarkers competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Biomarkers breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Neurological Biomarkers market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Biomarkers.
Chapter 14 and 15, to describe Neurological Biomarkers sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Neurological Biomarkers Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Proteomics
1.3.3 Genomics
1.3.4 Imaging
1.3.5 Bioinformatics
1.3.6 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Neurological Biomarkers Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Diagnostics
1.4.3 Drug Discovery
1.4.4 Personalized Medicine
1.4.5 Others
1.5 Global Neurological Biomarkers 麻豆原创 Size & Forecast
1.5.1 Global Neurological Biomarkers Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Neurological Biomarkers Sales Quantity (2020-2031)
1.5.3 Global Neurological Biomarkers Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Neurological Biomarkers Product and Services
2.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Neurological Biomarkers Product and Services
2.2.4 Merck Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Merck Recent Developments/Updates
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Neurological Biomarkers Product and Services
2.3.4 Quest Diagnostics Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Quest Diagnostics Recent Developments/Updates
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Neurological Biomarkers Product and Services
2.4.4 Abbott Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Abbott Recent Developments/Updates
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Neurological Biomarkers Product and Services
2.5.4 Roche Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Roche Recent Developments/Updates
2.6 Illumina
2.6.1 Illumina Details
2.6.2 Illumina Major Business
2.6.3 Illumina Neurological Biomarkers Product and Services
2.6.4 Illumina Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Illumina Recent Developments/Updates
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Neurological Biomarkers Product and Services
2.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Bio-Rad Laboratories Recent Developments/Updates
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN Neurological Biomarkers Product and Services
2.8.4 QIAGEN Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 QIAGEN Recent Developments/Updates
2.9 Myriad RBM
2.9.1 Myriad RBM Details
2.9.2 Myriad RBM Major Business
2.9.3 Myriad RBM Neurological Biomarkers Product and Services
2.9.4 Myriad RBM Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Myriad RBM Recent Developments/Updates
2.10 Cisbio Bioassays
2.10.1 Cisbio Bioassays Details
2.10.2 Cisbio Bioassays Major Business
2.10.3 Cisbio Bioassays Neurological Biomarkers Product and Services
2.10.4 Cisbio Bioassays Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Cisbio Bioassays Recent Developments/Updates
2.11 Athena Diagnostics
2.11.1 Athena Diagnostics Details
2.11.2 Athena Diagnostics Major Business
2.11.3 Athena Diagnostics Neurological Biomarkers Product and Services
2.11.4 Athena Diagnostics Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Athena Diagnostics Recent Developments/Updates
2.12 BGI
2.12.1 BGI Details
2.12.2 BGI Major Business
2.12.3 BGI Neurological Biomarkers Product and Services
2.12.4 BGI Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 BGI Recent Developments/Updates
2.13 Wuxi APP
2.13.1 Wuxi APP Details
2.13.2 Wuxi APP Major Business
2.13.3 Wuxi APP Neurological Biomarkers Product and Services
2.13.4 Wuxi APP Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Wuxi APP Recent Developments/Updates
2.14 Aepodia
2.14.1 Aepodia Details
2.14.2 Aepodia Major Business
2.14.3 Aepodia Neurological Biomarkers Product and Services
2.14.4 Aepodia Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Aepodia Recent Developments/Updates
2.15 Proteome Sciences
2.15.1 Proteome Sciences Details
2.15.2 Proteome Sciences Major Business
2.15.3 Proteome Sciences Neurological Biomarkers Product and Services
2.15.4 Proteome Sciences Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Proteome Sciences Recent Developments/Updates
2.16 Genewiz
2.16.1 Genewiz Details
2.16.2 Genewiz Major Business
2.16.3 Genewiz Neurological Biomarkers Product and Services
2.16.4 Genewiz Neurological Biomarkers Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Genewiz Recent Developments/Updates
3 Competitive Environment: Neurological Biomarkers by Manufacturer
3.1 Global Neurological Biomarkers Sales Quantity by Manufacturer (2020-2025)
3.2 Global Neurological Biomarkers Revenue by Manufacturer (2020-2025)
3.3 Global Neurological Biomarkers Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Neurological Biomarkers by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Neurological Biomarkers Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Neurological Biomarkers Manufacturer 麻豆原创 Share in 2024
3.5 Neurological Biomarkers 麻豆原创: Overall Company Footprint Analysis
3.5.1 Neurological Biomarkers 麻豆原创: Region Footprint
3.5.2 Neurological Biomarkers 麻豆原创: Company Product Type Footprint
3.5.3 Neurological Biomarkers 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neurological Biomarkers 麻豆原创 Size by Region
4.1.1 Global Neurological Biomarkers Sales Quantity by Region (2020-2031)
4.1.2 Global Neurological Biomarkers Consumption Value by Region (2020-2031)
4.1.3 Global Neurological Biomarkers Average Price by Region (2020-2031)
4.2 North America Neurological Biomarkers Consumption Value (2020-2031)
4.3 Europe Neurological Biomarkers Consumption Value (2020-2031)
4.4 Asia-Pacific Neurological Biomarkers Consumption Value (2020-2031)
4.5 South America Neurological Biomarkers Consumption Value (2020-2031)
4.6 Middle East & Africa Neurological Biomarkers Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Neurological Biomarkers Sales Quantity by Type (2020-2031)
5.2 Global Neurological Biomarkers Consumption Value by Type (2020-2031)
5.3 Global Neurological Biomarkers Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Neurological Biomarkers Sales Quantity by Application (2020-2031)
6.2 Global Neurological Biomarkers Consumption Value by Application (2020-2031)
6.3 Global Neurological Biomarkers Average Price by Application (2020-2031)
7 North America
7.1 North America Neurological Biomarkers Sales Quantity by Type (2020-2031)
7.2 North America Neurological Biomarkers Sales Quantity by Application (2020-2031)
7.3 North America Neurological Biomarkers 麻豆原创 Size by Country
7.3.1 North America Neurological Biomarkers Sales Quantity by Country (2020-2031)
7.3.2 North America Neurological Biomarkers Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Neurological Biomarkers Sales Quantity by Type (2020-2031)
8.2 Europe Neurological Biomarkers Sales Quantity by Application (2020-2031)
8.3 Europe Neurological Biomarkers 麻豆原创 Size by Country
8.3.1 Europe Neurological Biomarkers Sales Quantity by Country (2020-2031)
8.3.2 Europe Neurological Biomarkers Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Neurological Biomarkers Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Neurological Biomarkers Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Neurological Biomarkers 麻豆原创 Size by Region
9.3.1 Asia-Pacific Neurological Biomarkers Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Neurological Biomarkers Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Neurological Biomarkers Sales Quantity by Type (2020-2031)
10.2 South America Neurological Biomarkers Sales Quantity by Application (2020-2031)
10.3 South America Neurological Biomarkers 麻豆原创 Size by Country
10.3.1 South America Neurological Biomarkers Sales Quantity by Country (2020-2031)
10.3.2 South America Neurological Biomarkers Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Neurological Biomarkers Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Neurological Biomarkers Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Neurological Biomarkers 麻豆原创 Size by Country
11.3.1 Middle East & Africa Neurological Biomarkers Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Neurological Biomarkers Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Neurological Biomarkers 麻豆原创 Drivers
12.2 Neurological Biomarkers 麻豆原创 Restraints
12.3 Neurological Biomarkers Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Neurological Biomarkers and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurological Biomarkers
13.3 Neurological Biomarkers Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurological Biomarkers Typical Distributors
14.3 Neurological Biomarkers Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
听
听
*If Applicable.
